POTEH
gene geneOn this page
Also known as POTE22CT104.7
Summary
POTEH (POTE ankyrin domain family member H, HGNC:133) is a protein-coding gene on chromosome 22q11.1, encoding POTE ankyrin domain family member H (Q6S545). It is a selective cancer dependency (DepMap: 13.9% of cell lines).
Predicted to be located in membrane.
Source: NCBI Gene 23784 — RefSeq curated summary.
At a glance
- Clinical variants (ClinVar): 98 total
- Cancer dependency (DepMap): dependent in 13.9% of screened cell lines
- MANE Select transcript:
NM_001136213
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:133 |
| Approved symbol | POTEH |
| Name | POTE ankyrin domain family member H |
| Location | 22q11.1 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | POTE22, CT104.7 |
| Ensembl gene | ENSG00000198062 |
| Ensembl biotype | protein_coding |
| OMIM | 608913 |
| Entrez | 23784 |
Gene structure
Transcript identifiers
Ensembl transcripts: 2 — 1 protein_coding, 1 nonsense_mediated_decay
ENST00000343518, ENST00000452800
RefSeq mRNA: 1 — MANE Select: NM_001136213
NM_001136213
CCDS: CCDS74808
Canonical transcript exons
ENST00000343518 — 11 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001413705 | 15690026 | 15690709 |
| ENSE00001746577 | 15695371 | 15695485 |
| ENSE00001788239 | 15695645 | 15695818 |
| ENSE00003523951 | 15710868 | 15711034 |
| ENSE00003533849 | 15702686 | 15702756 |
| ENSE00003535920 | 15708020 | 15708090 |
| ENSE00003539333 | 15709782 | 15709826 |
| ENSE00003563151 | 15719660 | 15719778 |
| ENSE00003623625 | 15700078 | 15700215 |
| ENSE00003639359 | 15698662 | 15698768 |
| ENSE00003711518 | 15721286 | 15721631 |
Expression profiles
Bgee: expression breadth tissue_specific, 10 present calls, max score 85.23.
Top tissues by expression
114 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 85.23 | gold quality |
| prostate gland | UBERON:0002367 | 62.83 | gold quality |
| testis | UBERON:0000473 | 54.96 | gold quality |
| right testis | UBERON:0004534 | 52.82 | gold quality |
| left testis | UBERON:0004533 | 52.29 | gold quality |
| bone marrow cell | CL:0002092 | 42.90 | gold quality |
| lower esophagus mucosa | UBERON:0035834 | 41.93 | silver quality |
| tonsil | UBERON:0002372 | 39.20 | gold quality |
| skeletal muscle tissue | UBERON:0001134 | 39.10 | gold quality |
| ganglionic eminence | UBERON:0004023 | 37.25 | gold quality |
| colonic epithelium | UBERON:0000397 | 37.20 | gold quality |
| sural nerve | UBERON:0015488 | 36.64 | gold quality |
| ventricular zone | UBERON:0003053 | 36.48 | gold quality |
| cortical plate | UBERON:0005343 | 36.47 | gold quality |
| mucosa of transverse colon | UBERON:0004991 | 36.20 | gold quality |
| muscle tissue | UBERON:0002385 | 35.27 | gold quality |
| bone marrow | UBERON:0002371 | 35.19 | gold quality |
| right uterine tube | UBERON:0001302 | 34.38 | gold quality |
| lymph node | UBERON:0000029 | 33.79 | gold quality |
| mucosa of stomach | UBERON:0001199 | 32.30 | gold quality |
| hindlimb stylopod muscle | UBERON:0004252 | 32.15 | gold quality |
| urinary bladder | UBERON:0001255 | 31.99 | silver quality |
| calcaneal tendon | UBERON:0003701 | 31.35 | gold quality |
| liver | UBERON:0002107 | 30.35 | gold quality |
| monocyte | CL:0000576 | 30.33 | gold quality |
| primary visual cortex | UBERON:0002436 | 30.30 | gold quality |
| leukocyte | CL:0000738 | 30.08 | gold quality |
| adult mammalian kidney | UBERON:0000082 | 29.93 | silver quality |
| stromal cell of endometrium | CL:0002255 | 29.87 | gold quality |
| prefrontal cortex | UBERON:0000451 | 29.70 | gold quality |
Single-cell (SCXA)
Detected in 2 experiment(s), a significant marker in 1.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | yes | 3.11 |
| E-HCAD-30 | no | 11.41 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
13 targeting POTEH, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-3692-3P | 99.98 | 70.27 | 2139 |
| HSA-MIR-627-3P | 99.90 | 71.42 | 3316 |
| HSA-MIR-3202 | 99.66 | 67.70 | 2737 |
| HSA-MIR-6758-3P | 99.57 | 67.55 | 1078 |
| HSA-MIR-6797-3P | 99.17 | 66.94 | 668 |
| HSA-MIR-382-3P | 98.83 | 67.10 | 1074 |
| HSA-MIR-760 | 98.81 | 66.65 | 1392 |
| HSA-MIR-548Q | 98.71 | 65.35 | 563 |
| HSA-MIR-6076 | 98.61 | 65.69 | 637 |
| HSA-MIR-4691-5P | 98.41 | 66.77 | 1343 |
| HSA-MIR-6792-3P | 98.41 | 66.86 | 1359 |
| HSA-MIR-3670 | 97.88 | 64.39 | 763 |
| HSA-MIR-7855-5P | 97.39 | 67.18 | 925 |
Functional genomics
DepMap (CRISPR cell-line fitness): dependent in 13.9% of screened cell lines.
Cross-species orthologs
0 orthologs
Paralogs (16): BCL3 (ENSG00000069399), NFKBIE (ENSG00000146232), POTED (ENSG00000166351), POTEC (ENSG00000183206), POTEG (ENSG00000187537), POTEE (ENSG00000188219), POTEA (ENSG00000188877), POTEF (ENSG00000196604), POTEI (ENSG00000196834), POTEM (ENSG00000222036), POTEJ (ENSG00000222038), POTEB2 (ENSG00000230031), POTEB (ENSG00000233917), (ENSG00000276760), (ENSG00000277630), POTEB3 (ENSG00000278522)
Protein
Protein identifiers
POTE ankyrin domain family member H — Q6S545 (reviewed: Q6S545)
Alternative names: ANKRD26-like family C member 3, Prostate, ovary, testis-expressed protein on chromosome 22
All UniProt accessions (2): Q6S545, H0YG78
UniProt curated annotations — full annotation on UniProt →
Similarity. Belongs to the POTE family.
Isoforms (2)
| UniProt ID | Names | Canonical? |
|---|---|---|
| Q6S545-1 | 1 | yes |
| Q6S545-2 | 2 |
RefSeq proteins (1): NP_001129685* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR002110 | Ankyrin_rpt | Repeat |
| IPR036770 | Ankyrin_rpt-contain_sf | Homologous_superfamily |
| IPR050657 |
Pfam: PF12796
UniProt features (14 total): repeat 7, compositionally biased region 3, chain 1, splice variant 1, sequence conflict 1, region of interest 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q6S545-F1 | 63.45 | 0.37 |
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 15 (showing top):
ZWANG_TRANSIENTLY_UP_BY_2ND_EGF_PULSE_ONLY, FOXN3_TARGET_GENES, KMT2D_TARGET_GENES, SMCHD1_TARGET_GENES, ZNF618_TARGET_GENES, GSE10239_MEMORY_VS_KLRG1INT_EFF_CD8_TCELL_UP, MIR760, MYBL1_TARGET_GENES, GSE8835_HEALTHY_VS_CLL_CD4_TCELL_DN, GSE23925_DARK_ZONE_VS_NAIVE_BCELL_DN, GSE17301_CTRL_VS_48H_ACD3_ACD28_STIM_CD8_TCELL_DN, GSE11961_FOLLICULAR_BCELL_VS_GERMINAL_CENTER_BCELL_DAY40_UP, GSE11961_GERMINAL_CENTER_BCELL_DAY7_VS_MEMORY_BCELL_DAY40_DN, GSE28737_WT_VS_BCL6_KO_MARGINAL_ZONE_BCELL_DN, chr22q11
GO Biological Process (0):
GO Molecular Function (1): protein binding (GO:0005515)
GO Cellular Component (1): membrane (GO:0016020)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| binding | 1 |
| cellular anatomical structure | 1 |
Protein interactions and networks
STRING
1481 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| POTEH | ATP5MGL | Q7Z4Y8 | 434 |
| POTEH | SPATA45 | Q537H7 | 432 |
| POTEH | OR6K3 | Q8NGY3 | 432 |
| POTEH | CCT8L2 | Q96SF2 | 425 |
| POTEH | OR11H1 | Q8NG94 | 420 |
| POTEH | RIMBP3B | A6NNM3 | 417 |
| POTEH | SLC35E4 | Q6ICL7 | 397 |
| POTEH | C1orf141 | Q5JVX7 | 370 |
| POTEH | RGPD4 | Q7Z3J3 | 355 |
| POTEH | TMEM121B | Q9BXQ6 | 351 |
| POTEH | RIMBP3C | A6NJZ7 | 349 |
| POTEH | XKR3 | Q5GH77 | 340 |
| POTEH | SEMA4A | Q9H3S1 | 337 |
| POTEH | DDTL | A6NHG4 | 329 |
| POTEH | LENEP | Q9Y5L5 | 327 |
IntAct
3 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| MME | psi-mi:“MI:0914”(association) | 0.350 | |
| POTEG | POTEF | psi-mi:“MI:0914”(association) | 0.350 |
BioGRID (1): POTEH (Affinity Capture-MS)
ESM2 similar proteins: A0A0A6YYL3, A0JP26, A2A2Z9, A2RUR9, A6NC57, A6NI47, A6QR20, A8MYB1, A9JSR5, A9ZSY0, B2RU33, B7ZQJ9, F1M5M3, H3BUK9, O15050, P51954, P98182, Q19UN5, Q4UJ75, Q501X2, Q5CZ79, Q5DW34, Q5SQ80, Q5TYW2, Q5VUR7, Q66HB6, Q6NSI1, Q6S545, Q6S5H5, Q6S8J7, Q71S21, Q7TPV2, Q7TSC3, Q7ZT11, Q80X59, Q811D2, Q86Y13, Q86YR6, Q8IVF6, Q8IYA2
Diamond homologs: A0A0A6YYL3, A0JP26, A0PJZ0, A2A2Z9, A2RUR9, A5A3E0, A6NC57, A6NI47, A7E2S9, B2RU33, H3BUK9, P0CG38, P0CG39, Q3MJ40, Q4R3S3, Q4UJ75, Q5CZ79, Q5JPF3, Q5SQ80, Q5TYW2, Q5VUR7, Q6NSI1, Q6S545, Q6S5H5, Q6S8J3, Q6S8J7, Q811D2, Q86YR6, Q8IYA2, Q92527, Q9BXX2, Q9BXX3, Q9D504, Q9H560, Q9UPS8, Q8IVF6, A6QL64, Q8N2N9, Q8NF67, Q96IX9
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
98 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 86 |
| Likely benign | 10 |
| Benign | 1 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
1267 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 22:15690706:T:TA | donor_gain | 1.0000 |
| 22:15690708:CCT:C | donor_gain | 1.0000 |
| 22:15695368:C:CC | acceptor_gain | 1.0000 |
| 22:15695369:CCTA:C | acceptor_gain | 1.0000 |
| 22:15695370:TC:T | acceptor_gain | 1.0000 |
| 22:15695370:TCCTA:T | acceptor_loss | 1.0000 |
| 22:15695373:CAGTC:C | acceptor_gain | 1.0000 |
| 22:15695484:C:CT | donor_loss | 1.0000 |
| 22:15695485:ACCTT:A | donor_loss | 1.0000 |
| 22:15695488:CATA:C | donor_loss | 1.0000 |
| 22:15695627:C:CT | acceptor_gain | 1.0000 |
| 22:15695817:CCTT:C | donor_loss | 1.0000 |
| 22:15695818:ACCT:A | donor_loss | 1.0000 |
| 22:15695819:TA:T | donor_loss | 1.0000 |
| 22:15695820:ATAC:A | donor_loss | 1.0000 |
| 22:15695821:TATAC:T | donor_loss | 1.0000 |
| 22:15695822:CTATA:C | donor_loss | 1.0000 |
| 22:15698661:TG:T | acceptor_gain | 1.0000 |
| 22:15698663:CATG:C | acceptor_gain | 1.0000 |
| 22:15698764:T:A | donor_gain | 1.0000 |
| 22:15700074:T:A | acceptor_loss | 1.0000 |
| 22:15700075:C:CC | acceptor_gain | 1.0000 |
| 22:15700075:C:T | acceptor_loss | 1.0000 |
| 22:15700076:TC:T | acceptor_loss | 1.0000 |
| 22:15700077:TT:T | acceptor_gain | 1.0000 |
| 22:15700078:GTT:G | acceptor_gain | 1.0000 |
| 22:15700078:GTTC:G | acceptor_loss | 1.0000 |
| 22:15700079:AGTT:A | acceptor_gain | 1.0000 |
| 22:15700080:CAGTT:C | acceptor_gain | 1.0000 |
| 22:15700187:C:CC | donor_gain | 1.0000 |
AlphaMissense
3667 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 22:15695645:G:C | A250P | 0.956 |
| 22:15690696:G:C | D207H | 0.952 |
| 22:15690628:C:A | A184D | 0.947 |
| 22:15700094:G:C | A349P | 0.941 |
| 22:15695385:T:C | L216P | 0.940 |
| 22:15698719:T:C | F327L | 0.939 |
| 22:15698721:T:A | F327L | 0.939 |
| 22:15698721:T:G | F327L | 0.939 |
| 22:15695388:C:A | A217D | 0.937 |
| 22:15695682:T:C | L262S | 0.937 |
| 22:15698686:G:C | G316R | 0.928 |
| 22:15695387:G:C | A217P | 0.927 |
| 22:15695457:A:T | D240V | 0.927 |
| 22:15695744:G:C | A283P | 0.927 |
| 22:15700095:C:A | A349D | 0.927 |
| 22:15695815:C:A | N306K | 0.925 |
| 22:15695815:C:G | N306K | 0.925 |
| 22:15695458:C:A | D240E | 0.924 |
| 22:15695458:C:G | D240E | 0.924 |
| 22:15695371:G:C | R211S | 0.922 |
| 22:15695371:G:T | R211S | 0.922 |
| 22:15690698:C:A | D207E | 0.919 |
| 22:15690698:C:G | D207E | 0.919 |
| 22:15695456:G:C | D240H | 0.918 |
| 22:15698687:G:A | G316D | 0.917 |
| 22:15695376:C:A | A213D | 0.914 |
| 22:15700122:T:A | V358D | 0.914 |
| 22:15690627:G:C | A184P | 0.913 |
| 22:15700131:T:C | L361P | 0.910 |
| 22:15698723:T:C | L328S | 0.908 |
dbSNP variants (sampled 300 via entrez): RS1000082583 (22:15689994 C>A,G,T), RS1000454450 (22:15688130 T>A,C), RS1001727527 (22:15694327 C>A), RS1002095574 (22:15702114 A>G), RS1002160125 (22:15696363 C>G,T), RS1002467575 (22:15700641 A>G), RS1003709697 (22:15709091 A>G), RS1004015518 (22:15719568 A>G), RS1005576790 (22:15691873 A>G), RS1005933673 (22:15697849 C>G), RS1006014132 (22:15693260 T>C), RS1006318254 (22:15697252 T>C), RS1007578149 (22:15704494 G>C), RS1007936158 (22:15718845 C>G,T), RS1008329063 (22:15716603 A>G)
Disease associations
OMIM: gene MIM:608913 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
0 associations (top):
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
5 total (human), top 5 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Amiodarone | increases expression | 1 |
| Benzo(a)pyrene | increases methylation | 1 |
| Calcitriol | increases expression, affects cotreatment | 1 |
| Testosterone | affects cotreatment, increases expression | 1 |
| Aflatoxin B1 | decreases methylation | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.